Dr. Shu received his M.D. degree (Clinical Medicine) from Wannan Medical College in 2006, and a Ph.D. degree (Pharmacology) from Sun Yat-sen University in 2011. From 2011 to 2017, he was a postdoctoral scholar (Virology and Oncology) at The University of Chicago. He joined the faculty at Fudan University in 2017. Dr. Shu ‘s research interests focus on the epigenetic regulation of the tumor microenvironment and gene therapy, particularly on the regulation of RNA modification and metabolism and on the use of the herpes simplex virus to remodel the tumor-immune microenvironment.